Update tot 28-05-2020 1. COVID-19, Australia: Epidemiology Report 14 (Reporting week to 23:59 AEST 3 May 2020). Communicable diseases intelligence (2018). 2020;44. 2. COVID-19, Australia: Epidemiology Report 15 (Reporting week to 23:59 AEST 10 May 2020). Communicable diseases intelligence (2018). 2020;44. http://dx.doi.org/10.33321/cdi.2020.44.43. 3. Erratum: COVID-19, Australia: Epidemiology Report 14 (Reporting week to 23:59 AEST 3 May 2020). Communicable diseases intelligence (2018). 2020;44. http://dx.doi.org/10.33321/cdi.2020.44.44. 4. Metformin and COVID-19: A novel deal of an Old Drug. A.A ELA, Abdalla M. Journal of Medical Virology. 2020. 5. The mutual effects of COVID-19 and obesity. Abbas AM, Fathy SK, Fawzy AT, Salem AS, Shawky MS. Obesity Medicine. 2020;19. 6. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review. Aboughdir M, Kirwin T, Abdul Khader A, Wang B. Viruses. 2020;12(5). 7. Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients. Abrishami A, Samavat S, Behnam B, Arab-Ahmadi M, Nafar M, Sanei Taheri M. European Urology. 2020. 8. COVID-19 and lung cancer: risks, mechanisms and treatment interactions. Addeo A, Obeid M, Friedlaender A. J Immunother Cancer. 2020;8(1). http://dx.doi.org/10.1136/jitc-2020-000892. 9. 5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection. Ahmad SI. Med Hypotheses. 2020;142:109754. http://dx.doi.org/10.1016/j.mehy.2020.109754. 10. The accuracy of “Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data”. Ahmadi A, Kheiril S, Mohammadian-Hafshejani A, Raeisi H, Mosavi M, Sharifi H. International Journal of Infectious Diseases. 2020;95:319-20. 11. Pharmacological options in treating SARS-CoV-2 infection/COVID-19. Ákos F, István L, Marianna J, Mariann B, Tamás V, György K, et al. Orvosi Hetilap. 2020;161(17):685-8. 12. Turkish Cardiology Association Consensus Report: COVID-19 Pandemic and Cardiovascular Diseases (May 13, 2020). Aktoz M, Altay H, Aslanger E, Atalar E, Atar İ, Aytekin V, et al. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2020;48:1-87. 13. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. Kidney international. 2020. http://dx.doi.org/10.1016/j.kint.2020.04.030. 14. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Albini A, Di Guardo G, Noonan DM, Lombardo M. Internal and emergency medicine. 2020. http://dx.doi.org/10.1007/s11739-020-02364-6. 15. Guidelines for dental care provision during the COVID-19 pandemic. Alharbi A, Alharbi S, Alqaidi S. Saudi Dental Journal. 2020;32(4):181-6. 16. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: A rapid systematic review and meta-analysis. Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. PLoS ONE. 2020;15(5). 17. Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide? Al-Tawfiq JA, Leonardi R, Fasoli G, Rigamonti D. Travel Medicine and Infectious Disease. 2020. 18. Molecular mechanisms for thrombosis risk in black people: a role in excess mortality from Covid-19. Amasamy R, Milne KM, Stoneham SM, Chevassut TJ. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16869. 19. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Amawi H, Abu Deiab GI, Aa AA, Dua K, Tambuwala MM. Therapeutic delivery. 2020;11(4):245-68. http://dx.doi.org/10.4155/tde-2020-0035. Epub 2020 May 12. 20. Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection. Ameratunga R, Lehnert K, Leung E, Comoletti D, Snell R, Woon ST, et al. The New Zealand medical journal. 2020;133(1515):112-8. 21. What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control? Amimo F, Lambert B, Magit A. Tropical medicine and health. 2020;48:32. http://dx.doi.org/10.1186/s41182-020-00219-6. eCollection 2020. 22. Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic. Anders HJ, Bruchfeld A, Fernandez Juarez GM, Floege J, Goumenos D, Turkmen K, et al. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2020. http://dx.doi.org/10.1093/ndt/gfaa112. 23. Chilblains in children in the setting of COVID-19 pandemic. Andina D, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas JA, Escalada-Pellitero S, et al. Pediatric dermatology. 2020. 24. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Angelo Vaira L, Hopkins C, Salzano G, Petrocelli M, Melis A, Cucurullo M, et al. Head & neck. 2020. http://dx.doi.org/10.1002/hed.26269. 25. Does communicable diseases (including COVID-19) may increase global poverty risk? A cloud on the horizon. Anser MK, Yousaf Z, Khan MA, Nassani AA, Alotaibi SM, Qazi Abro MM, et al. Environmental Research. 2020;187. 26. COVID-19: a novel coronavirus and a novel challenge for critical care. Arabi YM, Murthy S, Webb S. Intensive Care Medicine. 2020;46(5):833-6. 27. Mapping the incidence of the COVID-19 hotspot in Iran – Implications for Travellers. Arab-Mazar Z, Sah R, Rabaan AA, Dhama K, Rodriguez-Morales AJ. Travel Medicine and Infectious Disease. 2020;34. 28. Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. JAMA - Journal of the American Medical Association. 2020;323(16):1612-4. 29. Anticipating the “Second Wave” of Health Care Strain in the COVID-19 Pandemic. Argulian E. JACC: Case Reports. 2020;2(5):845-6. 30. Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients. Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, et al. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16852. 31. Insights from immuno-oncology: The Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19. Ascierto PA, Fox B, Urba W, Anderson AC, Atkins MB, Borden EC, et al. Journal for ImmunoTherapy of Cancer. 2020;8(1). 32. Management of patients with COPD during the COVID-19 pandemic. Attaway A. Cleveland Clinic journal of medicine. 2020. 33. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. Atzrodt CL, Maknojia I, McCarthy RDP, Oldfield TM, Po J, Ta KTL, et al. The FEBS journal. 2020. http://dx.doi.org/10.1111/febs.15375. 34. Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California. Azar KMJ, Shen Z, Romanelli RJ, Lockhart SH, Smits K, Robinson S, et al. Health affairs (Project Hope). 2020:101377hlthaff202000598. http://dx.doi.org/10.1377/hlthaff.2020.00598. 35. Telehealth for High-Risk Pregnancies in the Setting of the COVID-19 Pandemic. Aziz A, Zork N, Aubey JJ, Baptiste CD, D'Alton ME, Emeruwa UN, et al. American journal of perinatology. 2020. 36. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, et al. Allergy. 2020. 37. A Chinese case of coronavirus disease 2019 (COVID-19) did not show infectivity during the incubation period: Based on an epidemiological survey. Bae JM. Journal of Preventive Medicine and Public Health. 2020;53(2):67-9. 38. Author response: Coronavirus disease 2019 (COVID-19), infectivity, and the incubation period. Bae JM. Journal of Preventive Medicine and Public Health. 2020;53(2):71. 39. What dentists need to know about COVID-19. Baghizadeh Fini M. Oral Oncology. 2020;105. 40. Covid-19 management: It's inappropriate to make judgments in hindsight that rely on information not available at the outset. Bamji AN. The BMJ. 2020;369. 41. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Banerjee A, Pasea L, Harris S, Gonzalez-Izquierdo A, Torralbo A, Shallcross L, et al. Lancet (London, England). 2020. 42. ‘Age and ageism in COVID-19’: Elderly mental health-care vulnerabilities and needs. Banerjee D. Asian Journal of Psychiatry. 2020;51. 43. COVID-19 Worries and Behavior Changes in Older and Younger Men and Women. Barber SJ, Kim H. The journals of gerontology Series B, Psychological sciences and social sciences. 2020. http://dx.doi.org/10.1093/geronb/gbaa068. 44. Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice. Barra S, Guarnieri A, di Monale EBMB, Marcenaro M, Tornari E, Belgioia L, et al. La Radiologia medica. 2020. http://dx.doi.org/10.1007/s11547-020-01216-9. 45. Covid-19 and infection in health-care workers: An emerging problem. Barranco R, Ventura F. The Medico-legal journal. 2020:25817220923694. http://dx.doi.org/10.1177/0025817220923694. 46. A Proposed Plan for Prenatal Care to Minimize Risks of COVID-19 to Patients and Providers: Focus on Hypertensive Disorders of Pregnancy.